Moody’s reviews Takeda Pharmaceutical’s ratings for downgrade
Moody’s Japan K.K. has placed the A1 issuer and senior unsecured ratings of Takeda Pharmaceutical Company Limited under review for […]
Say something
-
-
Flipkart Health+ App Launched
06-04-2022
